Trust Company of Toledo’s OnKure Therapeutics OKUR Stock Holding History

Trust Company of Toledo’s Portfolio OKUR Stock Details OKUR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$620	Hold	136	–	–	﹤0.01%	846
2026 Q1	$563	Hold	136	–	–	﹤0.01%	796
2025 Q4	$394	Hold	136	–	–	﹤0.01%	757
2025 Q3	$374	Hold	136	–	–	﹤0.01%	770
2025 Q2	$325	Buy	+136	New	+$357	﹤0.01%	769

Other funds holding OKUR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Trust Company of Toledo's OKUR Position: Q2 2026 in Review

Trust Company of Toledo held its OnKure Therapeutics (OKUR) position steady in Q2 2026 at 136 shares worth $620. The position accounts for ﹤0.01% of the portfolio, ranked #846.

Trust Company of Toledo first reported a position in OKUR in Q2 2025 and has held it in 5 quarters since. 13 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

Trust Company of Toledo held 136 shares of OnKure Therapeutics worth $620 as of Q2 2026.
Trust Company of Toledo left its OnKure Therapeutics share count unchanged in Q2 2026.
OnKure Therapeutics made up ﹤0.01% of Trust Company of Toledo's portfolio in Q2 2026, its #846 holding.
Trust Company of Toledo first reported a position in OnKure Therapeutics in Q2 2025 and has held it in 5 quarters since.
13 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Trust Company of Toledo's 13F filing for Q2 2026, filed 16 Jul 2026.